Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal
Year.
On March 15, 2023, Propanc Biopharma, Inc. (the "Company"), filed a certificate
with the Secretary of State of Delaware (the "Certificate of Retirement"),
effecting the retirement and cancellation of the Company's Series A Preferred
Stock (the "Series A Preferred Stock") to eliminate from its Certificate of
Incorporation, as amended (the "Certificate of Incorporation"), all references
to the Series A Preferred Stock, including, without limitation, the Certificate
of Designation governing the Series A Preferred Stock. No shares of Series A
Preferred Stock are currently outstanding.
Pursuant to Section 243(b) of the General Corporation Law of the State of
Delaware, once the Certificate of Retirement became effective, it had the effect
of amending the Certificate of Incorporation to eliminate all references to the
Series A Preferred Stock. The retired shares were returned to the status of
authorized but unissued shares of preferred stock, par value $0.01 per share, of
the Company, without designation as to series.
The foregoing description of the Certificate of Retirement does not purport to
be complete and is qualified in its entirety by reference to the full text of
the Certificate of Retirement, which is filed as Exhibit 3.15 to this Current
Report on Form 8-K and is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits:
Exhibit No. Description
3.15* Certificate of Retirement of Series A Preferred Stock of the
Company, dated March 15, 2023.
104 Cover Page Interactive Data File (embedded within the Inline XBRL
document)
* Filed herewith
2
© Edgar Online, source Glimpses